| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Accepted on ,
From the Carolina Cardiovascular Biology Center (X.P., C.P.) and the Division of Cardiology (C.P.), University of North Carolina, Chapel Hill.
* To whom correspondence should be addressed. E-mail: cpatters{at}med.unc.edu.
Related Article:
This article has been cited by other articles:
![]() |
T. Imanishi, H. Tsujioka, H. Ikejima, A. Kuroi, S. Takarada, H. Kitabata, T. Tanimoto, Y. Muragaki, S. Mochizuki, M. Goto, et al. Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes Hypertension, September 1, 2008; 52(3): 563 - 572. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |